Promising Cancer “Vaccine” Is Set To Begin Human Trials

An immune system-boosting cancer treatment that recently demonstrated astounding results in mice is now advancing to human testing.

Published less than two months ago in Science Translational Medicine, a study by Stanford University researchers showed that injection of two immune-stimulating agents directly into a tumor caused T-cells to recognize and destroy cancerous cells in both the local tumor as well as a distantly located secondary mass.

Because the combination treatment provokes an immune response and can be easily administered by an injection, the scientists have referred to it as a cancer “vaccine”, although technically speaking it is not a true vaccine.

Normally, T-cells are infective against tumors because the malignant cells within are either too similar to healthy cells to be recognized or the cancerous cells actually excrete chemicals that allow them to go undetected.

admin

Leave a Reply

Your email address will not be published. Required fields are marked *